Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03033055
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CRA | 1-DEOXY-1-METHOXYCARBAMIDO-BETA- D-GLUCO-2-HEPTULOPYRANOSONAMIDE | A | 1FS4 | 0.71 | |
CRA | 1-DEOXY-1-METHOXYCARBAMIDO-BETA- D-GLUCO-2-HEPTULOPYRANOSONAMIDE | A | 1B4D | 0.71 | |
HMN | 2,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDO NONANOIC ACID | A,B,C,D | 1F73 | 0.88 | |
BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 1L7G | 0.71 | |
BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 2HTU | 0.71 | |
BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 2F10 | 0.71 | |
BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 1L7H | 0.71 | |
BCZ | 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)- 4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID | A | 1L7F | 0.71 | |
LP5 | (R)-((2R,3S,4R,5R,6R)-3-HYDROXY- 2-(HYDROXYMETHYL)-5-((R)-3-HYDROXYTETRADECANAMIDO)- 6-(PHOSPHONOOXY)TETRAHYDRO-2H-PYRAN- 4-YL) 3-HYDROXYTETRADECANOATE | A | 2E59 | 0.7 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.71 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.71 | |
GSL | (2S,3R)-3-HYDROXY-2-(TETRADECANOYLAMINO)OCTADECYL ALPHA- D-GALACTOPYRANOSIDURONIC ACID | A | 2FIK | 0.74 | |
NGC | 3,5-dideoxy-5-[(hydroxyacetyl)amino]- D-glycero-alpha-D-galacto-non-2- ulopyranosonic acid | A,B,C,D,E | 3DWP | 0.79 | |
NGC | 3,5-dideoxy-5-[(hydroxyacetyl)amino]- D-glycero-alpha-D-galacto-non-2- ulopyranosonic acid | A,B,C,D,E | 3DWQ | 0.79 | |
AMK | (S)-4-AMINO-4-{(S)-1-[(S)-2-CARBAMOYL- 1-((S)-1-{(S)-[(1R,2R)-2-((S)-1- CARBOXY-ETHYLCARBAMOYL)-CYCLOPENTYL]- HYDROXY-METHYL}-3-METHYL-BUTYLCARBAMOYL)- ETHYLCARBAMOYL]-2-METHYL-PROPYLCARBAMOYL}- BUTYRIC ACID | A,B,C | 1YM4 | 0.72 | |
GNA | 2,4-DEOXY-4-GUANIDINO-5-N-ACETYL- NEURAMINIC ACID | A | 2QWE | 0.72 | |
LP4 | (R)-((2R,3S,4R,5S)-2-(HYDROXYMETHYL)- 5-((R)-3-HYDROXYTETRADECANAMIDO)- 3-(PHOSPHONOOXY)TETRAHYDRO-2H-PYRAN- 4-YL) 3-HYDROXYTETRADECANOATE | A | 2E59 | 0.71 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3I | 0.78 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 1KQR | 0.78 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B,C,D,E,F | 1HGH | 0.78 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B | 2I2S | 0.78 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3J | 0.78 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B,C,D,E,F | 1HGE | 0.78 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3K | 0.78 | |
GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B | 1UR9 | 0.73 | |
GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B,C,D,E,F | 1O7A | 0.73 | |
GDL | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5- LACTONE | A,B | 1UR8 | 0.73 | |
NAU | 4,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDONONANOIC ACID | A,C | 1F7B | 0.86 | |
ABW | 5-[1-(ACETYLAMINO)-3-METHYLBUTYL]- 2,5-ANHYDRO-3,4-DIDEOXY-4-(METHOXYCARBONYL)PENTONIC ACID | A | 1XOG | 0.77 | |
AMN | 9-DEOXY-9-AMINO-2-O-METHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGJ | 0.79 | |
G28 | 5-N-ACETYL-4-AMINO-6-DIETHYLCARBOXAMIDE- 4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID | A | 2QWJ | 0.74 | |
G28 | 5-N-ACETYL-4-AMINO-6-DIETHYLCARBOXAMIDE- 4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID | A | 2QWG | 0.74 | |
ANA | 4-O-ACETYL-ALPHA-2-OMETHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGI | 0.78 | |
NAY | 6,7,8,9-TETRAHYDROXY-5-METHYLCARBOXAMIDO- 2-OXONONANOIC ACID | A,C | 1F74 | 0.89 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2AH2 | 0.8 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2FHR | 0.8 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2A75 | 0.8 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A,B | 2VK7 | 0.8 | |
NAV | 6,7,8,9-TETRAHYDROXY-5-METHYLCARBOXAMIDO- 4-OXONONANOIC ACID | A,C | 1F7B | 0.86 |